Product logins

Find logins to all Clarivate products below.


Open Surgery Instruments | Market Insights | US | 2022

In 2020, the procedure deferrals due to the COVID-19 pandemic severely impacted the US open surgery instrument market. However, the overall market for open surgery devices in the US will exhibit moderate growth over the forecast period, driven largely by rising penetration of direct energy and closure devices in open procedures as well as the increasing adoption of premium-priced products although rising laparoscopic procedure penetration—and consequently declining open procedure volumes—will hamper market expansion.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for open surgery instruments in the US across an 11-year period.

Related Medtech Insights Reports

Report
ENT Devices – Market Insights – United States
The US ENT device market will grow modestly over the forecast period, with the nasal packing and myringotomy/tympanostomy device segments seeing the fastest growth rates. The market will be…
Report
Gastrointestinal Endoscopy Devices – Market Insights – United States
The US GI endoscopy device market is projected to experience modest expansion through 2034. The market growth is being driven by supportive treatment and screening guidelines, the growing use of AI…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Japan
The Japanese GI endoscopy device market is projected to experience modest expansion through 2034. This growth is driven by favorable treatment and screening guidelines, as well as an aging…
Report
Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Asia Pacific
The GI endoscopy device market will continue to grow moderately throughout the forecast period, supported by the high incidence of gastric cancer and CRC cases in the region. Growth will be…